Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Advertising and Sponsorship
    • Profile & Readership
    • Contact Us
    • Latest News
    • Privacy & Cookies Policies
    • Terms of Use
    • Advertising Terms
    • Issue 81
    • Issue 80
    • Issue 79
    • Issue 78
    • Issue 77
    • Issue 76
    • Issue 75
    • Issue 74
    • Issue 73
    • Issue 72
    • Issue 71
    • Issue 70
    • View All
    • About the Awards
    • Awards Timetable
    • Awards Winners
    • Submit Nominations
    • Testimonials
    • Media Room
    • FAQ
    • Asset Management Awards
    • Brand of the Year Awards
    • Business Awards
    • Cash Management Banking Awards
    • Banking Technology Awards
    • CEO Awards
    • Customer Service Awards
    • CSR Awards
    • Deal of the Year Awards
    • Corporate Governance Awards
    • Corporate Banking Awards
    • Digital Transformation Awards
    • Fintech Awards
    • Education & Training Awards
    • ESG & Sustainability Awards
    • ESG Awards
    • Forex Banking Awards
    • Innovation Awards
    • Insurance & Takaful Awards
    • Investment Banking Awards
    • Investor Relations Awards
    • Leadership Awards
    • Islamic Banking Awards
    • Real Estate Awards
    • Project Finance Awards
    • Process & Product Awards
    • Telecommunication Awards
    • HR & Recruitment Awards
    • Trade Finance Awards
    • The Next 100 Global Awards
    • Wealth Management Awards
    • Travel Awards
    • Years of Excellence Awards
    • Publishing Principles
    • Ownership & Funding
    • Corrections Policy
    • Editorial Code of Ethics
    • Diversity & Inclusion Policy
    • Fact Checking Policy
    Original content: Global Banking and Finance Review - https://www.globalbankingandfinance.com

    A global financial intelligence and recognition platform delivering authoritative insights, data-driven analysis, and institutional benchmarking across Banking, Capital Markets, Investment, Technology, and Financial Infrastructure.

    Copyright © 2010-2026 - All Rights Reserved. | Sitemap | Tags

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    1. Home
    2. >Finance
    3. >Trump meets Novartis CEO, says drugmaker building 11 US plants
    Finance

    Trump Meets Novartis Ceo, Says Drugmaker Building 11 US Plants

    Published by Global Banking & Finance Review®

    Posted on February 20, 2026

    2 min read

    Last updated: April 3, 2026

    Add as preferred source on Google
    Trump meets Novartis CEO, says drugmaker building 11 US plants - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:Manufacturing

    Quick Summary

    At a Rome, Georgia event, Trump said after meeting Novartis CEO Vas Narasimhan that the drugmaker is building 11 U.S. plants, crediting tariffs. Novartis cited NC and CA groundbreakings and plans for radioligand manufacturing in Florida.

    Trump Meets Novartis Chief, Says Drugmaker Plans 11 U.S. Plants

    Novartis U.S. Expansion and Tariff Context

    ROME, Georgia, Feb 19 (Reuters) - U.S. President Donald Trump said he met Vas Narasimhan, the chief executive officer of Swiss drugmaker Novartis, at the White House on Wednesday.

    White House Meeting and Claims

    Trump, addressing workers at a steel plant in Rome, Georgia on Thursday, said Narasimhan told him during the meeting that his company was building 11 U.S. plants as a result of the president's tariff policies.

    North Carolina and California Projects

    Company Statement on Facilities

    "We appreciate the opportunity to update the U.S. government on our progress, including recent groundbreakings for manufacturing and research facilities in North Carolina and California and plans to expand our radioligand therapy manufacturing network with a new site in Florida," a spokesperson for Novartis told Reuters in an emailed statement.

    Details Pending on Facility Count

    The statement did not add any details on the number of facilities planned in the U.S.

    Prior U.S. Investment Plans

    Last year, the Swiss drugmaker said it planned to spend $23 billion to build and expand 10 facilities in the U.S. after the Trump administration threatened to impose drug import duties.    

    Reporting and Editing Credits

    (Reporting by Trevor Hunnicutt and Sneha SK, Additional reporting by Abu Sultan in Bengaluru; Writing by Andrea Shalal, Editing by Bhargav Acharya and Kate Mayberry)

    References

    • Trump meets Novartis CEO, says drugmaker building 11 US plants (Reuters via Yahoo Finance)
    • Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida – Novartis media release (Jan 9, 2026)

    Table of Contents

    • Novartis U.S. Expansion and Tariff Context
    • White House Meeting and Claims
    • North Carolina and California Projects

    Key Takeaways

    • •Trump met Novartis CEO Vas Narasimhan at the White House.
    • •Trump claimed Novartis is building 11 U.S. plants linked to tariff policies.
    • •Novartis cited recent groundbreakings in North Carolina and California.
    • •The company plans to expand its radioligand therapy manufacturing in Florida.
    • •Novartis previously outlined a $23B plan to build/expand 10 U.S. facilities.

    Frequently Asked Questions about Trump meets Novartis CEO, says drugmaker building 11 US plants

    1What is the main topic?

    Trump said after meeting Novartis CEO Vas Narasimhan that the company is building 11 U.S. plants, linking the move to his tariff policies. Novartis highlighted recent and planned U.S. facilities.

    2Which U.S. facilities did Novartis mention?

    A spokesperson cited recent groundbreakings in North Carolina and California and plans to expand its radioligand therapy manufacturing network with a site in Florida.

    3
  • Company Statement on Facilities
  • Details Pending on Facility Count
  • Prior U.S. Investment Plans
  • Reporting and Editing Credits
  • Did Novartis confirm building 11 plants?

    No. While Trump cited 11 plants, Novartis did not specify a total number in its statement. Previously, it outlined $23B to build and expand 10 U.S. facilities.

    More from Finance

    Explore more articles in the Finance category

    Image for Iran war may boost already rising support for euro in Bulgaria, central banker says
    Iran War May Boost Already Rising Support for Euro in Bulgaria, Central Banker Says
    Image for Inflation scars risk quickly lifting expectations; ECB must be ready to act: policymaker
    Inflation Scars Risk Quickly Lifting Expectations; ECB Must Be Ready to Act: Policymaker
    Image for Morning Bid: A breakthrough deal or a crude awakening?
    Morning Bid: A Breakthrough Deal or a Crude Awakening?
    Image for UK new car sales grew 6% in March, industry data shows
    UK New Car Sales Grew 6% in March, Industry Data Shows
    Image for Chinese pigs fed new menu as Beijing weans farmers off US soy
    Chinese Pigs Fed New Menu as Beijing Weans Farmers Off US Soy
    Image for Apple's foldable iPhone encounters engineering snags, faces potential shipment delays, Nikkei Asia reports
    Apple's Foldable iPhone Encounters Engineering Snags, Faces Potential Shipment Delays, Nikkei Asia Reports
    Image for Taiwan opposition chief leaves for China 'peace' mission, minister details warship deployments
    Taiwan Opposition Chief Leaves for China 'peace' Mission, Minister Details Warship Deployments
    Image for Stocks struggle, oil jumps as Trump's Iran deadline looms
    Stocks Struggle, Oil Jumps as Trump's Iran Deadline Looms
    Image for Exclusive-SpaceX lays out IPO details, targets early June roadshow, sources say
    Exclusive-SpaceX Lays Out IPO Details, Targets Early June Roadshow, Sources Say
    Image for Dollar kept aloft as another Trump deadline looms
    Dollar Kept Aloft as Another Trump Deadline Looms
    Image for Analysis-Asian airlines trim schedules and carry extra fuel as supplies tighten
    Analysis-Asian Airlines Trim Schedules and Carry Extra Fuel as Supplies Tighten
    Image for US crude oil futures rise over $1 as Trump sharpens rhetoric on Iran
    US Crude Oil Futures Rise Over $1 as Trump Sharpens Rhetoric on Iran
    View All Finance Posts
    Previous Finance PostSika Reports Better-Than-Expected Annual Profit
    Next Finance PostNovartis to Exit India Unit in $159 Million Deal; Mumbai-Listed Shares Surge 20%